2007
DOI: 10.1016/j.ijcard.2006.06.017
|View full text |Cite
|
Sign up to set email alerts
|

The metabolic syndrome and nonfatal ischemic heart disease; a population-based study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
27
2

Year Published

2009
2009
2016
2016

Publication Types

Select...
7
1

Relationship

4
4

Authors

Journals

citations
Cited by 52 publications
(30 citation statements)
references
References 29 publications
1
27
2
Order By: Relevance
“…Considering different levels of the outcome variable (10-y CVD risks of ≥ 7.5%, 4 Hepat Mon. 2017; 17(1):e43901.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Considering different levels of the outcome variable (10-y CVD risks of ≥ 7.5%, 4 Hepat Mon. 2017; 17(1):e43901.…”
Section: Discussionmentioning
confidence: 99%
“…Based on a previous study, CVDs accounted for nearly 40% of mortality in Tehran, the capital city of Iran (3). A study of a random sample of 3723 subjects from an Iranian population demonstrated that 11.3% of the population had coronary symptoms and about 1.4% had experienced myocardial infarctions (3,4).…”
Section: Introductionmentioning
confidence: 99%
“…The Persian Gulf Healthy Heart Study, a prospective population based cohort study, was designed to determine the risk factors for cardiovascular diseases among the northern Persian Gulf population. Detailed information about the methods and procedures of this study is available elsewhere [26].…”
Section: Patients and Controlsmentioning
confidence: 99%
“…We selected an age-and sex-matched glucose-tolerant control group (49 men, 40 women, mean age 41.375 AE 9.47 years) from the Persian Gulf Healthy Heart Study participants [22] or subjects with no apparent disease history, who underwent a routine health checkup at General Clinic of Fatemeh-Zahra University Hospital. They had no family history of diabetes mellitus, type 2 diabetes or endocrine disorders, cardiovascular diseases, or hepatic or renal dysfunction and were not taking antirheumatic drugs and medications for metabolic diseases.…”
Section: Subjects and Physical Measurementsmentioning
confidence: 99%